Comprehensive analysis indicated that NDE1 is a potential biomarker for pan ‐cancer and promotes bladder cancer progression
ConclusionHigh expression of NDE1 is present in a variety of tumours, which is linked to a bad prognosis for cancer. Knockdown of NDE1 inhibited the proliferation, invasion and metastasis of bladder cancer cells, and promoted the apoptosis. For a number of malignancies, NDE1 may be a biomarker for immunotherapy and prognosis.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Peihan Wang,
Jinzhuo Ning,
Wu Chen,
Fan Zou,
Weimin Yu,
Ting Rao,
Fan Cheng Tags: RESEARCH ARTICLE Source Type: research
More News: Allergy & Immunology | Bladder Cancer | Cancer | Cancer & Oncology | Genetics | Immunotherapy | Study